Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024

Stevanato Group (STVN) to Report Q1 Results: What You Should Expect

Italy’s Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices

Stevanato Group appoints Ugo Gay as Chief Operations Officer

Here’s Why Stevanato (STVN) Declined in Q4

Here’s Why Stevanato Group S.p.A. (STVN) Shares Sold Off in Q4

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Stevanato Group Announces Public Offering of Ordinary Shares

Should You Hold Stevanato Group S.p.A. (STVN) for the Long-Term?

Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

TAK or STVN: Which Is the Better Value Stock Right Now?

Stevanato Group S.p.A. (NYSE:STVN) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Stevanato Group S.p.A. (NYSE:STVN) Q4 2023 Earnings Call Transcript

Stevanato Group Full Year 2023 Earnings: EPS Misses Expectations

Q4 2023 Stevanato Group SpA Earnings Call

Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023